Although all three patterns can be predictive of response to therapy with anti-PD-L1 antibodies, the functional significance of PD-L1 expression by tumour versus immune cells is unknown and represents a major limitation to our understanding of how the PD-1/PD-L1 axis regulates the anti-cancer T cell response. This evidence concerns the gene CD274 and cancer.